SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000318306-97-000003
Filing Date
1997-03-28
Accepted
1997-03-28 00:00:00
Documents
7
Period of Report
1996-12-31
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 149990
2 CERT. OF AMEND. OF CERT. OF INC. OF ACCESS PHARM. INC. EX-3.7 2739
3 PLATINATE HPMA COPOLYMER ROYALTY AGREEMENT EX-10.19 35955
4 SUBSIDIARIES OF THE REGISTRANT EX-21 214
5 INDEPENDENT AUDITORS' CONSENT EX-23.1 1394
6 INDEPENDENT AUDITORS' CONSENT EX-23.2 1082
7 FDS EX-27 1940
  Complete submission text file 0000318306-97-000003.txt   195616
Mailing Address 2600 N STEMMONS FRWY STE 210 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 210 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-09314 | Film No.: 97566752
SIC: 2834 Pharmaceutical Preparations